Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Atsuta

Showing results (11-20 of 602) with videos related to

Pageof 61
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Mentorship to support career development among women physicians]Yoshiko Atsuta, Marie Ohbiki, Emiko Sakaida, et al.
Nagoya Journal of Medical Science|July 29, 2004
Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University HospitalKazuko Nishio, Daisuke Tanaka, Yoshiko Atsuta, et al.
International Journal of Hematology|January 2, 2021
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational studyTakafumi Soejima, Masaaki Shiohara, Yasushi Ishida, et al.
International Journal of Hematology|February 27, 2007
Long-term follow-up of 14 patients with philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remissionShuichi Mizuta, Akio Kohno, Yoshihisa Morishita, et al.
Transplantation and Cellular Therapy|December 6, 2025
Optimizing Patient Selection for Reduced Nonrelapse Mortality After Reduced-Intensity Conditioning: A CIBMTR AnalysisYu Akahoshi, Nelli Bejanyan, Hideki Nakasone, et al.
International Journal of Hematology|August 24, 2015
Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myelomaIsamu Sugiura, Satomi Terabe, Tomohiro Kinoshita, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell dosesSeitaro Terakura, Eiichi Azuma, Makoto Murata, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2014
Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populationsYachiyo Kuwatsuka, Yoshiko Atsuta, Mary M Horowitz, et al.
Cell Transplantation|December 3, 2020
Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte GlobulinJunya Kanda, Toshihiko Ando, Shun-Ichi Kimura, et al.
Blood Cell Therapy|January 30, 2023
Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignanciesTakahiko Sato, Naomi Kawashima, Masafumi Ito, et al.
Pageof 61

Showing results (11-20 of 602) with videos related to

Sort By:
Pageof 61
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Mentorship to support career development among women physicians]Yoshiko Atsuta, Marie Ohbiki, Emiko Sakaida, et al.
Nagoya Journal of Medical Science|July 29, 2004
Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University HospitalKazuko Nishio, Daisuke Tanaka, Yoshiko Atsuta, et al.
International Journal of Hematology|January 2, 2021
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational studyTakafumi Soejima, Masaaki Shiohara, Yasushi Ishida, et al.
International Journal of Hematology|February 27, 2007
Long-term follow-up of 14 patients with philadelphia chromosome-positive acute lymphoblastic leukemia following autologous bone marrow transplantation in first complete remissionShuichi Mizuta, Akio Kohno, Yoshihisa Morishita, et al.
Transplantation and Cellular Therapy|December 6, 2025
Optimizing Patient Selection for Reduced Nonrelapse Mortality After Reduced-Intensity Conditioning: A CIBMTR AnalysisYu Akahoshi, Nelli Bejanyan, Hideki Nakasone, et al.
International Journal of Hematology|August 24, 2015
Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myelomaIsamu Sugiura, Satomi Terabe, Tomohiro Kinoshita, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell dosesSeitaro Terakura, Eiichi Azuma, Makoto Murata, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2014
Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populationsYachiyo Kuwatsuka, Yoshiko Atsuta, Mary M Horowitz, et al.
Cell Transplantation|December 3, 2020
Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte GlobulinJunya Kanda, Toshihiko Ando, Shun-Ichi Kimura, et al.
Blood Cell Therapy|January 30, 2023
Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignanciesTakahiko Sato, Naomi Kawashima, Masafumi Ito, et al.
Pageof 61